Programme: Bioscience 2022
07.45 Registration, networking at the exhibition and partnering meetings
08.15 Welcome and introduction
Johan Rockberg, moderator, KTH Royal Institute of Technology
Samuel Lagercrantz, Editor in Chief, Life Science Sweden
08.20 Developing pharmaceuticals against Alzheimer’s and pain
Martin Jönsson, CEO, AlzeCure Pharma
08.45 Innovative immunotherapy treatments for Alzheimer's disease and other neurodegenerative disorders
Johanna Fälting, Head of Research, BioArctic
09.10 Engineering mammalian cell factories for production of challenging biologics
Magdalena Malm, PhD, Department of Protein Science, KTH Royal Institute of Technology
09.35 ELISA and beyond
Rebecca Kilmartin, BioResearch Field Application Scientist, Avantor delivered by VWR (supplier Molecular Devices)
10.00 Coffee, networking at the exhibition and partnering meetings
10.40 Good fat and bad fat in cancer
Yihai Cao, Professor of Vascular Biology, Karolinska Institutet
11.05 Targeted inhibition of SAMHD1 enhances the treatment response in acute myeloid leukaemia – from bench to bedside in 5 years
Nikolas Herold, Associate Professor, Paediatric Oncology Astrid Lindgren Children’s Hospital & Karolinska Institutet
Martin Jädersten, MD/PhD, Department of Hematology, Karolinska University Hospital
11.30 Personalized T cell immunotherapy
Samuel Svensson, CEO, Neogap Therapeutics
11.55 Biobanking and Stockholm Region Biobank as a valuable resource for medical care and research in Sweden
Linda Lindskog, Operating Director, Stockholm Region Biobank & Head of Department Biobanking and Study Support, Karolinska University Hospital
12.20 Lunch, networking at the exhibition and partnering meetings
13.20 Artificial spider silk for technical and biomedical applications
Anna Rising, Professor in Veterinary Biochemistry, SLU; Group Leader, Karolinska Institutet
13.45 Development of protein domains for diagnostic and therapeutic use
Sophia Hober, Professor, Department of Protein Science, KTH Royal Institute of Technology
14.05 Targeting inflammation in thrombotic disease
Magnus Grenegård, Professor in Physiology, Örebro University
14.30 Coffee, networking at the exhibition and partnering meetings
15.00 Development of a lipid nanocapsule formulation as a drug delivery tool for retinal applications
Dileep Urimi, M.S. (Pharm.), RISE Research Institutes of Sweden
15.25 Neandertal gene variants influence the metabolism of commonly prescribed drugs
Hugo Zeberg, MD/PhD, Department of Neuroscience, Karolinska Institutet
15.45 Onstage interview with Hugo Zeberg
Samuel Lagercrantz, Editor in Chief, Life Science Sweden
15.55 Summary and conclusion
Samuel Lagercrantz, Editor in Chief, Life Science Sweden
16.00 Drinks, refreshments, networking at the exhibition and partnering meetings